DEFINITION of granulomatosis

Granulomatosis broadly refers to any condition or disease process characterized by the widespread development of granulomas (tiny clusters of white blood cells, primarily macrophages, that the immune system forms to wall off substances it perceives as foreign but cannot eliminate). While the term can describe a generalized state, in clinical coding and documentation, it is most frequently encountered in the context of severe systemic autoimmune vasculitides. The classic presentation is Granulomatosis with polyangiitis (GPA)—formerly known as Wegener’s granulomatosis—a rare, life-threatening autoimmune disorder causing necrotizing granulomatous inflammation of the blood vessels, predominantly affecting the upper respiratory tract (sinuses, nose, ears), lower respiratory tract (lungs), and the kidneys (glomerulonephritis). Another major variant is Eosinophilic granulomatosis with polyangiitis (EGPA), formerly Churg-Strauss syndrome, which is strongly associated with severe asthma and tissue eosinophilia. Furthermore, Chronic granulomatous disease (CGD) is a distinct primary immunodeficiency (usually X-linked) where phagocytes cannot create the reactive oxygen compounds needed to destroy certain bacteria and fungi, leading to severe, recurrent granulomatous infections. Clinical Indicators: For coding and documentation, coders should look for laboratory and pathology findings in the chart such as “c-ANCA positive” (highly specific for GPA), “p-ANCA positive” (EGPA), “necrotizing granulomas on biopsy,” “saddle nose deformity,” “cavitary lung lesions,” or evidence of rapidly progressive glomerulonephritis. The most critical distinction for ICD-10-CM coding of GPA is verifying whether the provider explicitly documented renal involvement, as this changes the code selection.


ETYMOLOGY of granulomatosis

latin greek

ComponentOriginMeaning
granul- / granulo-Latin granulum, diminutive of granum”Little grain, seed” — refers to the granular, seed-like macroscopic appearance of these tiny inflammatory nodules in tissue; underlying granulation, agranulocytosis
-omaAncient Greek -ωμα (-ōma)Noun suffix — “tumor, mass, fluid collection” — used here to denote a focal inflammatory mass rather than a true neoplasm; appears in carcinoma, hematoma, sarcoma
-osisAncient Greek -ωσις (-ōsis)Noun suffix — “condition, state, or disease process of” — indicating a widespread, systemic, or pathological state of forming these masses; appears in fibrosis, leukocytosis

Literally: “Condition of forming little grain-like masses.” A granuloma is the individual lesion; adding the -osis suffix elevates it to a systemic disease state. Historically, the most famous variant was named Wegener’s granulomatosis after Friedrich Wegener, who described it in 1936. However, due to his associations with the Nazi regime, the medical community officially shifted the nomenclature to Granulomatosis with polyangiitis (GPA) in 2011. Both terms still map to the same ICD-10-CM block.


🔀 ALIASES / ALTERNATE TERMS

TermContext
Granulomatosis with polyangiitis (GPA)The modern, preferred clinical term for Wegener’s; emphasizes the underlying vessel inflammation
Wegener’s granulomatosisEponymous historical term; deprecated in modern literature but still widely seen in older charts and physician notes
Eosinophilic granulomatosis with polyangiitis (EGPA)The modern term for Churg-Strauss syndrome; characterized by asthma, eosinophilia, and granulomatous vasculitis
Churg-Strauss syndromeHistorical eponym for EGPA
Chronic granulomatous disease (CGD)A genetic immunodeficiency affecting neutrophils, completely distinct etiologically from the autoimmune polyangiitis variants

🔗 RELATED TERMS

  • GranulomaL92.9 (Skin) or J84.112 (Lung); the singular, localized inflammatory lesion itself. Granulomatosis is the systemic disease state.
  • Polyangiitis — Inflammation of many blood vessels; the fundamental pathological process driving the tissue destruction in GPA and EGPA.
  • SarcoidosisD86.9; another major systemic granulomatous disease, but characterized specifically by non-caseating (non-necrotizing) granulomas, unlike GPA.
  • TuberculosisA15.9; a classic infectious cause of granulomas, specifically caseating (cheese-like necrosis) granulomas in the lungs.
  • Macrophage — The primary phagocytic immune cell that aggregates and transforms into epithelioid cells and multinucleated giant cells to form the physical structure of the granuloma.
  • ANCA (Antineutrophil cytoplasmic antibodies) — The autoantibodies heavily implicated in driving the pathogenesis of GPA (c-ANCA) and EGPA (p-ANCA).

CODING CORNER


🏥 ICD-10-CM CODES

Primary Diagnosis — Granulomatosis with Polyangiitis (GPA / Wegener’s)

⚠️ ICD-10-CM / Chapter Nuances: GPA is classified under Systemic Connective Tissue Diseases (Chapter 13). The coding branches definitively based on the presence or absence of renal (kidney) involvement.

CodeDescription
M31.30Wegener’s granulomatosis without renal involvement (Default code if renal disease/glomerulonephritis is absent or not documented)
M31.31Wegener’s granulomatosis with renal involvement (Requires provider documentation linking kidney dysfunction/failure to the GPA)

Other Granulomatosis Syndromes

CodeDescription
M30.1Polyarteritis with lung involvement [Churg-Strauss] (The specific ICD-10 code for EGPA)
D71Functional disorders of polymorphonuclear neutrophils (Includes Chronic Granulomatous Disease [CGD])
L92.0Granuloma annulare (A distinct, benign, self-limiting localized skin condition, not a systemic vasculitis)

🔧 COMMON CPT CODES (Granulomatosis Evaluation & Biopsy)

Diagnostic Procedures (Biopsies)

⚠️ CPT Nuance: Because GPA heavily affects the respiratory tract, diagnosis usually requires tissue sampling from the sinuses or lungs to find the necrotizing granulomas.

CPT CodeDescription
31237Nasal/sinus endoscopy, surgical; with biopsy, polypectomy or debridement (Commonly used to biopsy inflamed sinus tissue in suspected GPA)
31628Bronchoscopy, rigid or flexible, including fluoroscopic guidance; with transbronchial lung biopsy(s), single lobe (Used to biopsy cavitary lung lesions)
31510Laryngoscopy, indirect; with biopsy (If granulomatous lesions are affecting the upper airway/vocal cords)

Laboratory Testing (Immunology)

CPT CodeDescription
86021Antibody identification; leukocyte antibodies (Used for ANCA testing, vital for diagnosing and monitoring GPA/EGPA)
88305Level IV - Surgical pathology, gross and microscopic examination (Billed by the pathologist reviewing the sinus/lung tissue for granulomas)

Modifiers Commonly Used

ModifierUsage
-26Professional component — Append to pathology or lab codes (88305) if the physician is interpreting the results but the facility owns the lab equipment.
-RT / -LTRight side / Left side — Crucial for surgical biopsies (like sinus endoscopy 31237) to specify the anatomical side sampled.
-59Distinct procedural service — Used if a biopsy is performed on a completely different anatomical site or lesion during the same operative session.

⚠️ Coding Note: The most frequent clinical documentation error regarding Granulomatosis with polyangiitis (GPA) is failing to capture systemic organ involvement. If a rheumatologist or nephrologist notes that the patient’s creatinine is elevated or they have glomerulonephritis due to GPA, you must code M31.31 (with renal involvement), which carries a higher risk adjustment value than M31.30. Do not code the glomerulonephritis separately unless payer guidelines specifically demand dual coding; the M31.31 code inherently captures the renal manifestation. Additionally, while the medical community has strongly adopted the term “GPA,” the ICD-10-CM alphabetical index still heavily relies on “Wegener’s.” If a provider documents “GPA,” you must trace it through “granulomatosis Wegener’s” to arrive at the correct M31.3x block.



Med roots Appendix A Prefixes Appendix B Combining Forms Appendix C Suffixes Appendix D Suffix forms